Haznedaroglu, Ibrahim C. “MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 6, no. 1, Dec. 2013, p. e2014009, doi:10.4084/mjhid.2014.009.